Method of treating lymphoproliferative syndrome

摘要: Lymphoproliferative syndrome, including such diseases as malignant lymphoma, chronic lymphocytic leukemia, Hodgkin's and non-Hodgkin's is treated in human patients by the administration a pharmacologically effective mode or route of an essentially pure opiate receptor antagonist, typified Naltrexone Naloxone, exerting substantially higher blocking action for Mu sites than against Delta at low dose concentration which produces therapeutic results corresponding to those obtained dosage level range 1.0 mg. 10 activity most small significant preferably exclusive. suitable oral preferred.